Although in vitro studies have provided evidence for microglial activation in PD [2, 3], investigation of TSPO radioligand binding is to our knowledge limited to a study of tissue samples from three PD patients [44] that showed a marked increase, albeit with high within-group variability. This evidence concerns the gene TSPO and Parkinson disease.